1-6 of 6
Jan J. Molenaar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with Cancer

Open Access
Gilles Vassal, Peter J. Houghton, Stefan M. Pfister, Malcolm A. Smith, Huib N. Caron, Xiao-Nan Li, David J. Shields, Olaf Witt, Jan J. Molenaar, Sara Colombetti, Julia Schüler, Lou F. Stancato
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (8): 1462–1468.
https://doi.org/10.1158/1535-7163.MCT-20-0394
Published: 01 August 2021
View article titled, International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with Cancer
Open the PDF for International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with Cancer in another window
Includes: Supplementary data
Journal Articles

High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells

Free
Lindy Vernooij, Laurel T. Bate-Eya, Lindy K. Alles, Jasmine Y. Lee, Bianca Koopmans, Hunter C. Jonus, Nil A. Schubert, Linda Schild, Daphne Lelieveld, David A. Egan, Mark Kerstjens, Ronald W. Stam, Jan Koster, Kelly C. Goldsmith, Jan J. Molenaar, M. Emmy M. Dolman
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2021) 20 (6): 1161–1172.
https://doi.org/10.1158/1535-7163.MCT-20-0666
Published: 01 June 2021
View article titled, High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells
Open the PDF for High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells in another window
Includes: Supplementary data
Journal Articles

Abstract C104: High in vitro sensitivity of pediatric solid and hematological malignancies to the survivin-suppressant YM155.

Free
Arnauld C. Verschuur, Claudia Lanvers-Kaminsky, Jan J. Molenaar, Fieke G. Lamers, Taufik Ouatas, Aya Kita, Joachim Boos, Gilles Vassal, Huib C. Caron
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): C104.
https://doi.org/10.1158/1535-7163.TARG-11-C104
Published: 12 November 2011
View article titled, Abstract C104: High in vitro sensitivity of pediatric solid and hematological malignancies to the survivin-suppressant YM155.
Journal Articles

Abstract C114: The KidsCancerKinome: Validation of CDK2 as potential drug target in pediatric tumors

Free
Jan J. Molenaar, Ellen M. Westerhout, Monique L. Boer den, Steve C. Clifford, Olivier Delattre, Birgit Geoerger, Claudia Lanvers, Torsten Pietsch, Massimo Serra, Janet Shipley, Gilles Vassal, Rogier Versteeg, Arnauld C. Verschuur, Huib N. Caron
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C114.
https://doi.org/10.1158/1535-7163.TARG-09-C114
Published: 10 December 2009
View article titled, Abstract C114: The KidsCancerKinome: Validation of CDK2 as potential drug target in pediatric tumors
Journal Articles

Abstract C115: The KidsCancerKinome: Validation of Aurora kinases as potential drug targets in pediatric tumors

Free
Ellen M. Westerhout, Marcel Kool, Jan J. Molenaar, Monique L. Boer den, Steve C. Clifford, Olivier Delattre, Birgit Geoerger, Claudia Lanvers, Torsten Pietsch, Massimo Serra, Janet Shipley, Gilles Vassal, Rogier Versteeg, Arnauld C. Verschuur, Huib N. Caron
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C115.
https://doi.org/10.1158/1535-7163.TARG-09-C115
Published: 10 December 2009
View article titled, Abstract C115: The KidsCancerKinome: Validation of Aurora kinases as potential drug targets in pediatric tumors
Journal Articles

Abstract C116: The KidsCancerKinome: Validation of drug targets for high risk childhood cancers

Free
Huib N. Caron, Ellen M. Westerhout, Jan J. Molenaar, Monique L. Boer den, Steve C. Clifford, Olivier Delattre, Birgit Geoerger, Claudia Lanvers, Torsten Pietsch, Katia Scotlandi, Massimo Sera, Janet Shipley, Gilles Vassal, Rogier Versteeg, Arnauld Verschuur
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C116.
https://doi.org/10.1158/1535-7163.TARG-09-C116
Published: 10 December 2009
View article titled, Abstract C116: The KidsCancerKinome: Validation of drug targets for high risk childhood cancers